Robert J. Mentz

Active 2012–2025

Also published as
Robert J Mentz
244
Papers
24,199
Citations
83
h-index
223
i10-index

Citations

Citations per year for Robert J. Mentz1996: 1 citations2003: 1 citations2005: 1 citations2006: 1 citations2012: 8 citations2013: 20 citations2014: 25 citations2015: 53 citations2016: 68 citations2017: 87 citations2018: 163 citations2019: 664 citations2020: 833 citations2021: 897 citations2022: 932 citations2023: 929 citations2024: 2,025 citations2025: 1,167 citations2026: 38 citations1997–2002: no citations, so these years are not shown2004: no citations, so this year is not shown2007–2011: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,811 citing papers, 20.7% of this breakdownUnited Kingdom: 1,046 citing papers, 7.7% of this breakdownItaly: 865 citing papers, 6.4% of this breakdownChina: 752 citing papers, 5.5% of this breakdownCanada: 665 citing papers, 4.9% of this breakdownGermany: 658 citing papers, 4.9% of this breakdownNetherlands: 517 citing papers, 3.8% of this breakdownFrance: 422 citing papers, 3.1% of this breakdownSpain: 394 citing papers, 2.9% of this breakdownJapan: 351 citing papers, 2.6% of this breakdownAustralia: 337 citing papers, 2.5% of this breakdownSweden: 332 citing papers, 2.4% of this breakdown
0%20.7%Other 32.6%

Fields

  • Medicine88.9%
  • Biochemistry, Genetics and Molecular Biology4.2%
  • Health Professions1.6%
  • Engineering1.6%
  • Computer Science0.6%
  • Economics, Econometrics and Finance0.5%
  • Other2.6%

Topics

  • Heart Failure Treatment and Management12.8%
  • Diabetes Treatment and Management10.7%
  • Cardiovascular Function and Risk Factors8.9%
  • Pancreatic function and diabetes2.2%
  • Metabolism, Diabetes, and Cancer2.1%
  • Diabetes Management and Research1.9%
  • Other61.4%

Coauthors

All papers

Open in search
  1. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ESC Scientific Document Group, Rudolf A. de Boer, P. Christian Schulze, Elena Arbelo, Jozef Bartúnek, Johann Bauersachs, Michael A Borger, Sergio Buccheri, Elisabetta Cerbai, Erwan Donal, Frank Edelmann, Gloria Färber, Bettina Heidecker, Borja Ibanez, Stefan James, Lars Køber, Konstantinos C Koskinas, Josep Masip, John W. McEvoy, Robert J. Mentz, Borislava Mihaylova, Jacob Eifer Møller, Wilfried Müllens, Lis Neubeck, Jens Cosedis Nielsen, Agnès Pasquet, Piotr Ponikowski, Eva Prescott, Amina Rakisheva, Bianca Rocca, Xavier Rosselló, Leyla Elif Sade, Hannah Schaubroeck, Elena Tessitore, Mariya Tokmakova, Peter van der Meer, Isabelle C. Van Gelder, Mattias Van Heetvelde, Christiaan Vrints, Matthias Wilhelm, Adam Witkowski, Katja Zeppenfeld, Naltin Shuka, Mohammed Chettibi, Hamlet Hayrapetyan, Noémi Pávó, Aysel İslamlı, Anne–Catherine Pouleur, Zumreta Kušljugić, Mariya Tokmakova, Davor Miličić, Theodoros Christodoulides, Filip Málek, Lars Køber, M. Koriem, Pentti Põder, Johan Lassus, François Roubille, Vaja Agladze, Stefan Frantz, Alexia Stavrati, Annamária Kosztin, Inga Jóna Ingimarsdóttir, Patricia Campbell, Tal Hasin, Fabrizio Oliva, Nazipa Aidargaliyeva, Gani Bajraktari, Erkin М Мirrakhimov, Ginta Kamzola and 47 more - European Heart Journal 2023 cited by 2,187

  2. Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes

    Authors: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 cited by 2,143

  3. The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2022 cited by 895

  4. Physical Rehabilitation for Older Patients Hospitalized for Heart Failure

    Authors: , , , , , , , , , , , , - New England Journal of Medicine 2021 cited by 547

  5. Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update

    Authors: , , , , , , , , , , , , - Circulation 2019 cited by 619

  6. Ferric Carboxymaltose in Heart Failure with Iron Deficiency

    Authors: , , , , , , , , , , , , , , , - New England Journal of Medicine 2023 cited by 218

  7. Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure

    Authors: , , , , , , , , , , , , , - Journal of the American College of Cardiology 2023 cited by 163

  8. Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Modele O. Ogunniyi, Priyathama Vellanki, Brenda Murphy, Jonathan Newman, Justin Hartupee, Charu Gupta, Marcela Goldsmith, Paramdeep Baweja, Manuel Montero, Stephen S. Gottlieb, Maria Rosa Costanzo, Thanh T. Hoang, Alicia Warnock, Larry A. Allen, W.H. Wilson Tang, Horng H. Chen, John M. Cox - Circulation 2019 cited by 427

  9. Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , W.H. Wilson Tang, Yair Lev, Preethi William, Arthur L. Eberly, Stephen S. Gottleib, W. Herbert Haught, Gillian Grafton, Joshua Larned, Lokesh Tejwani, Freny Vaghaiwalla Mody, Selim R. Krim, Monique Robinson, James C. Fang, Alexander A. Adler, Adrian C. Bell, Dipanjan Banerjee, Ernesto A. Ruiz Duque, Ahmad Mizyed, John Rommel, Justice Arhinful, Parag Goyal, Michael E. Hall, Scott L. Hummel, Sanjay Shetty, Donald Haas, Juan Vilaro, Tamás Alexy, John M. Herre, J.M. Clark, Andrew P. Ambrosy, Nunzio Gaglianello, Kumudha Ramasubbu, Judith Meadows, Sara Tabtabai, Melody Sherwood, Syed Farhan Hasni, Michael D'Urso, Basharat Muneer, Stephanie H. Dunlap, William C. Davis, Dennis Friedman, Maya Guglin, Andrew D. Ferguson, Antonio Abbate, Frank W. Smart - JAMA 2023 cited by 181

  10. Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis

    Authors: , , , , , , , , , , - European Heart Journal 2023 cited by 126

  11. Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Aleksandr Parkhomenko, Piotr Ponikowski, Petar Seferović, Michele Senni, Е. V. Shlyakhto, Alain Cohen‐Solal, Peter Szecsödy, Klaus Jensen, Fabio Dorigotti, Matthew R. Weir, Bertram Pitt - European Heart Journal 2022 cited by 222

  12. Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis

    Authors: , , , , , , , , , , , , , , , , - The Lancet Diabetes & Endocrinology 2017 cited by 592

  13. 10-Year Risk Equations for Incident Heart Failure in the General Population

    Authors: , , , , , , , , , , , , - Journal of the American College of Cardiology 2019 cited by 195

  14. Exercise Intolerance in Older Adults With Heart Failure With Preserved Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2021 cited by 176

  15. Trends in Heart Failure–Related Mortality Among Older Adults in the United States From 1999-2019

    Authors: , , , , , , , , , - JACC Heart Failure 2022 cited by 136

  16. Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF

    Authors: , , , , , , , , , , , , , , , , - European Heart Journal 2023 cited by 120

  17. Sex Differences in Heart Failure

    Authors: , , , , , , , , , , , , - Journal of Cardiac Failure 2021 cited by 176

  18. Efficacy and Safety of Spironolactone in Acute Heart Failure

    Authors: , , , , , , , , , , , , , , , , - JAMA Cardiology 2017 cited by 306

  19. Palliative Care in Heart Failure

    Authors: , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2017 cited by 598

  20. Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE Trial

    Authors: , , , , , , , , , , , , , , , - Circulation 2022 cited by 143

  21. Demographic and Regional Trends of Heart Failure–Related Mortality in Young Adults in the US, 1999-2019

    Authors: , , , , , , , , , - JAMA Cardiology 2022 cited by 106

  22. Clinical applications of machine learning in the diagnosis, classification, and prediction of heart failure

    Authors: , , , , - American Heart Journal 2020 cited by 154

  23. Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure

    Authors: , , , , , , , , , , , , , , - Circulation Heart Failure 2015 cited by 328

  24. Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF

    Authors: , , , , , , , , , , , , , , , , , , , - Circulation 2022 cited by 92